I+D de fármacos
GI-1606
Universidad de Valparaíso
Valparaíso, ChilePublikationen in Zusammenarbeit mit Forschern von Universidad de Valparaíso (6)
2023
-
In silico approaches to develop new phenyl-pyrimidines as glycogen synthase kinase 3 (GSK-3) inhibitors with halogen-bonding capabilities: 3D-QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies
Journal of Biomolecular Structure and Dynamics, Vol. 41, Núm. 22, pp. 13250-13259
2022
2021
2020
-
3-Arylcoumarins as highly potent and selective monoamine oxidase B inhibitors: Which chemical features matter?
Bioorganic Chemistry, Vol. 101
2019
-
Design, Synthesis and Docking Calculations of Prenylated Chalcones as Selective Monoamine Oxidase B Inhibitors with Antioxidant Activity
ChemistrySelect, Vol. 4, Núm. 26, pp. 7698-7703
-
Novel Coumarin-Quinoline Hybrids: Design of Multitarget Compounds for Alzheimer's Disease
ChemistrySelect, Vol. 4, Núm. 2, pp. 551-558